|
FKBP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.64149999998453E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.681800E-03 |
| Normal-vs-Stage2 |
6.320500E-02 |
| Normal-vs-Stage3 |
4.137800E-02 |
| Normal-vs-Stage4 |
2.293600E-01 |
| Stage1-vs-Stage2 |
6.807800E-01 |
| Stage1-vs-Stage3 |
3.618800E-01 |
| Stage1-vs-Stage4 |
7.736800E-01 |
| Stage2-vs-Stage3 |
7.497000E-01 |
| Stage2-vs-Stage4 |
9.884400E-01 |
| Stage3-vs-Stage4 |
7.991200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.84550000000128E-05 |
| Normal-vs-AfricanAmerican |
8.078300E-03 |
| Normal-vs-Asian |
3.352000E-01 |
| Caucasian-vs-AfricanAmerican |
7.334200E-01 |
| Caucasian-vs-Asian |
5.810800E-01 |
| AfricanAmerican-vs-Asian |
6.073800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.751300E-04 |
| Normal-vs-Female |
2.15879999999613E-05 |
| Male-vs-Female |
6.923300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.510000E-01 |
| Normal-vs-Extreme_Weight |
3.382400E-02 |
| Normal-vs-Obese |
2.382800E-04 |
| Normal-vs-Extreme_Obese |
5.425400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.303400E-01 |
| Normal_Weight-vs-Obese |
1.590060E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.411800E-01 |
| Extreme_Weight-vs-Obese |
6.314300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.081000E-01 |
| Obese-vs-Extreme_Obese |
2.714600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.120000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.13379999997243E-06 |
| Normal-vs-Age(61-80Yrs) |
7.097500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.433200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.898000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.594440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.386300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.648000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.335990E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.883830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.70430000000699E-05 |
| Normal-VS-Type2 PRCC |
4.346800E-01 |
| Normal-VS-KIRP CIMP |
8.281700E-03 |
| Normal-VS-Unclassified PRCC |
3.196000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.170240E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.957800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.723790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.129860E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.284450E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.108200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.254200E-01 |
| Normal-vs-N1 |
3.251800E-02 |
| Normal-vs-N2 |
2.065200E-01 |
| N0-vs-N1 |
1.110820E-01 |
| N0-vs-N2 |
5.330400E-02 |
| N1-vs-N2 |
6.433000E-01 |
|
|
